Labcorp 

€202
94
+€0+0% Friday 06:06

Statistik

Harga Tertinggi Hari Ini
202
Harga Terendah Hari Ini
202
52M Tinggi
-
52M Rendah
-
Volume
0
Rata-Rata Volume
-
Kap Pasar
-
Rasio P/E
-
Hasil Dividen
1.3%
Dividen
2.62

Mendatang

Dividen

1.3%Hasil Dividen
Pertumbuhan 10T
T/A
Pertumbuhan 5T
T/A
Pertumbuhan 3T
T/A
Pertumbuhan 1T
T/A

Pendapatan

24OctDikonfirmasi
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Berikutnya
3.03
3.23
3.44
3.65
EPS yang Diharapkan
3.2531388735999998
EPS Aktual
T/A

Orang Juga Mengikuti

Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti N6B.F. Ini bukan rekomendasi investasi.

Peserta

Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.

Tentang

Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers.
Show more...
CEO
Mr. Adam H. Schechter
Karyawan
67000
Negara
US
ISIN
US5049221055
WKN
000A40C39

Daftar